IRVINE, Calif., April 2, 2009 (GLOBE NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced that two peer-reviewed journal articles summarizing clinical findings related to its Contura(tm) Multi-Lumen Balloon (MLB) Catheter are pending publication. These and other studies support our belief that a patient treated with Contura MLB receives a more targeted dose of radiation, while minimizing radiation to healthy tissue such as the skin and ribs. As a result, more patients are being treated with Contura MLB who previously were not candidates for accelerated partial breast radiation therapy. One article was published in Brachytherapy and a second has been accepted for publication in The American Surgeon:
